A detailed history of Fmr LLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Fmr LLC holds 555,524 shares of ARCT stock, worth $11.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
555,524
Previous 621,858 10.67%
Holding current value
$11.4 Million
Previous $21 Million 35.59%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$24.35 - $44.39 $1.62 Million - $2.94 Million
-66,334 Reduced 10.67%
555,524 $13.5 Million
Q1 2024

May 13, 2024

SELL
$31.23 - $42.99 $7.57 Million - $10.4 Million
-242,500 Reduced 28.06%
621,858 $21 Million
Q4 2023

Feb 13, 2024

SELL
$17.71 - $32.97 $1.34 Million - $2.5 Million
-75,923 Reduced 8.07%
864,358 $27.3 Million
Q3 2023

Nov 13, 2023

BUY
$25.44 - $37.35 $1.88 Million - $2.77 Million
74,081 Added 8.55%
940,281 $24 Million
Q2 2023

Aug 11, 2023

BUY
$23.94 - $32.36 $905,123 - $1.22 Million
37,808 Added 4.56%
866,200 $24.8 Million
Q1 2023

May 11, 2023

SELL
$14.72 - $23.97 $1.2 Million - $1.96 Million
-81,851 Reduced 8.99%
828,392 $19.9 Million
Q4 2022

Feb 13, 2023

SELL
$14.14 - $23.06 $623,319 - $1.02 Million
-44,082 Reduced 4.62%
910,243 $15.4 Million
Q3 2022

Nov 10, 2022

BUY
$13.05 - $22.13 $438,062 - $742,859
33,568 Added 3.65%
954,325 $14.1 Million
Q2 2022

Aug 12, 2022

SELL
$12.26 - $31.17 $478 - $1,215
-39 Reduced -0.0%
920,757 $14.5 Million
Q1 2022

May 13, 2022

BUY
$17.64 - $39.57 $4,798 - $10,763
272 Added 0.03%
920,796 $24.8 Million
Q4 2021

Feb 14, 2022

SELL
$34.2 - $47.56 $5.21 Million - $7.25 Million
-152,453 Reduced 14.21%
920,524 $34.1 Million
Q3 2021

Nov 15, 2021

BUY
$27.88 - $58.25 $9.55 Million - $20 Million
342,687 Added 46.92%
1,072,977 $51.3 Million
Q2 2021

Aug 13, 2021

BUY
$25.79 - $42.11 $18.8 Million - $30.8 Million
730,290 New
730,290 $24.7 Million

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $546M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.